Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$RWGI - Company Continues Expansion into the Licensed California Cannabis Market
https://www.otcmarkets.com/stock/RWGI/news/Rodedawg-Intl-Ind-Inc-OTC-RWGI-Signs-Binding-Letter-of-Intent-for-Cannabis-Manufacturing-Distribution-and-Delivery?id=407841
$TLRY $CRLBF $CRON $CURLF $IIPR $CGC $GTBIF $TCNNF $SNDL $TSNDF $JAZZ
$RONN NEWS IS OUT!!! Ronn Inc. Announces the Cancellation of 100 Million Common Shares https://finance.yahoo.com/news/ronn-inc-announces-cancellation-100-141500297.html
This was such an extensive and informative PR... Many things still to come!
$BLFR
$RONN proudly announced a transformative step towards carbon neutrality through an exclusive strategic agreement with NetZero, LLC. Under this agreement, Net Zero will undertake the registration, pre-sale and monetization of environmental credits on behalf of RONN. https://finance.yahoo.com/news/ronn-inc-signs-exclusive-agreement-134500359.html
$RWGI - Upcoming launch of www.BrotherBuds.com brand and the cannabis delivery service with conservative estimates at 6.7 Million annual revenue within 18 months of launch.
https://finance.yahoo.com/news/rodedawg-intl-ind-inc-otc-133000564.html
$TLRY $CRLBF $CRON $CURLF $IIPR $CGC $GTBIF $TCNNF $SNDL $TSNDF $JAZZ
Nitches (OTCPink: $NICH) Unveils Exciting Flavor Profiles for 2024 https://finance.yahoo.com/news/nitches-otcpink-nich-unveils-exciting-142000348.html
SmallCapVoice.com shines a spotlight a leader in innovative fire protection solutions. This undervalued gem is ready to change the game with its innovative system, utilizing patent-pending technology
The CEO of $TWOH stated "This collaboration with Smart for Life, Inc. ( NASDAQ: $SMFL ) unites the iconic stature of the Sports Illustrated brand with Two Hands Corp, positioning us for substantial growth in this market segment." https://accesswire.com/799662/two-hands-corporation-launches-sports-illustrated-line-protein-bars-in-canada
💯 #BREAKINGNEWS: #KNIT💥 Kinetic Group Inc., (OTC: $KNIT), http://knitgrp.com, has acquired 100% of US based BINNOPS US TECHNOLOGIES INC in an all stock transaction. https://finance.yahoo.com/news/kinetic-group-inc-finalizes-acquisition-132100899.html
💯 #BREAKINGNEWS: #KNIT🚨 Kinetic Group Inc., (OTC: $KNIT), https://t.co/MyZbYFC3vU, has acquired 100% of US based BINNOPS US TECHNOLOGIES INC in an all stock transaction. https://t.co/g2C2aKubkE@ipoguy @GetInEarly $ENZC $NWBO $NLST $VOCL $CLH $QRHC $RSG $CVA $NBTX $NLST $AVTX… pic.twitter.com/UtzVNx0FV4
— Stocks On High ALert💯 (@StockOnHighALer) January 3, 2024
BlueFire Equipment Corp (BLFR) Celebrates a Year of Major Achievements Leading to a Pivotal 2024
December 29, 2023
Click here:
https://www.publicnow.com/view/65ACC02BFACFE6385FB44055430A594C1478487B?1703857690
$TMGI News October 25, 2023
The Marquie Group Acquires INSANITEA and SANITEA Brands for New Nutritional Product Development
https://finance.yahoo.com/news/marquie-group-acquires-insanitea-sanitea-182900866.html
$TWOH is going to make us a lot of money adding from this level https://schrts.co/GXmzAFBT
$RWGI News: Rodedawg Intl. Ind, Inc. (OTC:RWGI) Acquires Parabola Mgmt., LLC
Acquisition Completes and Establishes Key Revenue Drivers
COSTA MESA, CA / ACCESSWIRE / December 27, 2023 / Rodedawg International Industries, Inc. (OTC PINK:RWGI) proudly announces the company has completed all terms and conditions of the Parabola Mgmt., LLC acquisition.
Chris Swartz, CEO, states: "We are proud to announce to our shareholders the completion of the acquisition of Parabola Mgmt. LLC. The acquisition included ownership of the California licensed cannabis company in Costa Mesa with options to purchase additional licenses. Most importantly, the Costa Mesa facility is now open, operational, and is geographically located in Southern California which is the #1 market in the world for cannabis. The completion of all terms for this acquisition of Parabola Mgmt. LLC is "the" major step for Rodedawg shareholders. Rodedawg now has a central sales hub for upcoming sales and distribution efforts. This has been a step-by-step process and we have strategically executed this key milestone. In addition to this acquisition, our shareholders can expect in the coming weeks that we will complete the acquisition of additional licensed cannabis distribution hubs and distribution contracts that will have 2024 revenues meet our stated goals of 7 million annually."
Chris Swartz, CEO, adds, "We want to remind our shareholders of the importance of these key milestones as we anticipate that these milestones completed during this 4th Quarter 2023 to be the catalyst of our company's revenue growth:
We are finalizing the agreements for distribution, management, and manufacturing of new cannabis products that increase revenues by an estimated 7 million dollars annually.
Our www.BrotherBuds.com team has finalized the product catalog and we will notify our shareholders of the launch of the cannabis delivery service.
We expect to announce acceptance of an offer for our new Healthcare Division Director. Primary responsibilities include the continued launch of and our flagship product of www.Elixicure.com, our topical pain relief brand.
We are currently in negotiation for an additional licensed cannabis distribution hub to be owned 100% by Rodedawg Intl. Ind. Inc.
Mr. Swartz concludes: "This is an exciting time for our company, and our team thanks our loyal shareholders for their ongoing support. We also want our shareholders to know that no reverse split is planned for the company."
About Rodedawg International Industries, Inc.
Rodedawg International Industries, Inc. (OTC PINK:RWGI) is focused on providing management services, acquisitions and restructuring resources throughout the regulated California cannabis market. We are a trusted partner and asset to licensed cultivation, distributors, manufacturers, and retail dispensaries.
Please note the company's Twitter address is https://twitter.com/RWGImerger for regular updates.
About Budding Horizon, LLC
Budding Horizon, LLC is California Limited Liability Company with offices in Orange County, California. The company is focused to providing management services for the licensed cannabis industry and seeks to leverage its expertise in the real estate acquisitions to acquire and develop a portfolio of assets.
The company website is https://buddinghorizon.com/
About Brother Buds
Brother Buds is a cannabis delivery service based in Costa Mesa, California. During the month of July 2023, the Rodedawg will operate Brother Buds under a non-storefront cannabis delivery license. The cannabis delivery service will focus on Los Angeles County, Orange County, and northern San Diego County in the demographic area of 23.86 million in 2019. The company is focused to providing management services for the licensed cannabis industry and seeks to leverage its expertise in the real estate acquisitions to acquire and develop a portfolio of assets.
The company website is https://BrotherBuds.com
Make sure to follow us at: https://twitter.com/BrotherBudsOC
Contact Information:
Rodedawg International Industries, Inc.
1-800-793-0355
ir@buddinghorizon.com
Safe Harbor Statement: In addition to historical information, this press release may contain statements that constitute forward-looking statements within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Forward-looking statements contained in this press release include the intent, belief, or expectations of the Company and members of its management team with respect to the Company's future business operations and the assumptions upon which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance, and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Factors that could cause these differences include, but are not limited to, failure to complete anticipated sales under negotiations, lack of revenue growth, client discontinuances, failure to realize improvements in performance, efficiency and profitability, and adverse developments with respect to litigation or increased litigation costs, the operation or performance of the Company's business units or the market price of its common stock. Additional factors that would cause actual results to differ materially from those contemplated within this press release can also be found on the Company's website. The Company disclaims any responsibility to update any forward-looking statements.
SOURCE: Rodedawg International Industries, Inc.
via PRISM Mediawire, LLC
Join $TWOH @TwoHandsGroup Two Hands Group at SRAX Sequire Investor Summit 2024, Puerto Rico! We're showcasing our innovative projects and growth strategies, connecting with global visionaries. A pivotal moment for investors to explore new horizons with us. #TwoHandsGroup #SequireSummit2024 #TWOH
Join $TWOH @TwoHandsGroup Two Hands Group at SRAX Sequire Investor Summit 2024, Puerto Rico! We're showcasing our innovative projects and growth strategies, connecting with global visionaries. A pivotal moment for investors to explore new horizons with us. #TwoHandsGroup #SequireSummit2024 $TWOH
$TWOH Two Hands Corporation Company launched a new X account https://twitter.com/TwoHandsGroup
$RNXT News: RenovoRx Engages Oklahoma University (OU) Health as First Clinical Site in Preparation for the Pivotal Phase III CouGar Clinical Trial in Bile Duct Cancer
This study will be the Second Clinical Trial Evaluating RenovoGem™, a Combination Drug-Device Product, in a Difficult-to-Access Solid Tumor Cancer
LOS ALTOS, Calif.--(BUSINESS WIRE)-- RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a clinical-stage biopharmaceutical company developing novel precision oncology therapies based on a local drug-delivery platform, today announced the expansion of their clinical development pipeline in preparation for the commencement of a second Phase III trial. The CouGar Trial will evaluate RenovoGem in bile duct cancer, specifically unresectable locally advanced extrahepatic cholangiocarcinoma (eCCA).
“We are pleased to engage our first clinical site for our second pivotal clinical trial. The CouGar Trial marks an important milestone for RenovoRx as we expand our clinical pipeline for RenovoGem into bile duct cancer, a difficult-to-treat solid tumor cancer,” said Leesa Gentry, Senior Vice President of Clinical Operations at RenovoRx. “I’m extremely proud of our team and our collaborators for their tremendous work reinforcing our mission to improve patient lives by delivering innovative therapies that can potentially change the current paradigm of cancer care.”
The pivotal Phase III CouGar study is a randomized study designed to evaluate the safety and efficacy of unresectable, locally advanced eCCA using intravenous cisplatin, gemcitabine, and durvalumab (all forms of chemotherapy) versus Trans-Arterial Micro-Perfusion via RenovoGem (delivery system and gemcitabine) with intravenous durvalumab. Oklahoma University (OU) Health is the first clinical site for the CouGar study.
“Unfortunately, bile duct cancer today has a poor prognosis for patients. Despite early diagnosis, the five-year survival rate is approximately 24%,” said Paula Novelli, MD FSIR, CouGar National Principal Investigator, and Associate Professor of Radiology and Director of Interventional Radiology Research at the University of Pittsburgh Medical Center. “There are currently limited treatment options for patients diagnosed with this aggressive cancer, which only prolongs life by a few months. The CouGar study brings hope for a new treatment option. RenovoGem has the potential to meet the urgent clinical need for a safe and effective therapy in this important patient population.”
Dr. David Geller, Director, UPMC Liver Cancer Center, Richard L. Simmons Professor of Surgery, University of Pittsburgh School of Medicine is the CouGar study’s Co-Investigator.
“The current standard of care for bile duct cancer is systemic (intravenous) chemotherapy, which has poor uptake and delivery since there are few blood vessels feeding this type of tumor,” said Dr. Hassan Hatoum, Principal Investigator, Associate Professor and Hematologist and Oncologist at Oklahoma University Health Stephenson Cancer Center – Gastrointestinal Cancer Clinic. “RenovoRx’s clinical trial is evaluating targeted, trans-arterial delivery of chemotherapy that is locally directed to the tumor site. Our team looks forward to participating in the CouGar study to bring this novel therapy to patients.”
RenovoGem received FDA Orphan Drug Designation for pancreatic cancer and bile duct cancer which provides 7 years of market exclusivity upon NDA approval.
About RenovoRx, Inc.
RenovoRx is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. The Company’s proprietary Trans-Arterial Micro-Perfusion (TAMPTM) therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy’s toxicities versus systemic (intravenous (IV) therapy). RenovoRx’s unique approach to targeted treatment offers the potential for increased safety, tolerance, and improved efficacy. Our Phase III lead product candidate, RenovoGemTM, a novel oncology drug-device combination product, is being investigated under a US IND that is regulated by FDA 21 CFR 312 pathway. RenovoGem is currently being evaluated for the treatment of locally advanced pancreatic cancer (LAPC) by the Center for Drug Evaluation and Research (the drug division of FDA.)
RenovoRx is committed to transforming the lives of patients by delivering innovative solutions to change the current paradigm of cancer care. RenovoGem is currently under investigation for TAMP therapeutic delivery of gemcitabine and has not been approved for commercial sale.
For more information, visit www.renovorx.com. Follow RenovoRx on Facebook, LinkedIn, and Twitter.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, including but not limited to statements regarding our clinical trials and studies, including anticipated timing, statements regarding the potential of RenovoCath®, RenovoGemTM or TAMPTM or regarding our ongoing TIGeR-PaC Phase III clinical trial study in LAPC, statements regarding the potential for our product candidates to treat or provide clinically meaningful outcomes for certain medical conditions or diseases, and our preliminary financial results, cash position and related ability to continue as a going concern. Statements that are not purely historical are forward-looking statements. The forward-looking statements contained herein are based upon our current expectations and beliefs regarding future events, many of which, by their nature, are inherently uncertain, outside of our control and involve assumptions that may never materialize or may prove to be incorrect. These may include estimates, projections and statements relating to our research and development plans, clinical trials, therapy platform, business plans, objectives and expected operating results, which are based on current expectations and assumptions that are subject to known and unknown risks and uncertainties that may cause actual results to differ materially from those expressed or implied by these forward-looking statements. These statements may be identified using words such as “may,” “expects,” “plans,” “aims,” “anticipates,” “believes,” “forecasts,” “estimates,” “intends,” and “potential,” or the negative of these terms or other comparable terminology regarding RenovoRx’s expectations strategy, plans or intentions, although not all forward-looking statements contain these words. These forward-looking statements are subject to a number of risks, uncertainties and assumptions, that could cause actual events to differ materially from those projected or indicated by such statements, including, among other things: the timing of the initiation, progress and potential results of our preclinical studies, clinical trials and our research programs; the possibility that interim results may not be predictive of the outcome of our clinical trial, which may not demonstrate sufficient safety and efficacy to support regulatory approval of our product candidate, or the regulatory authority may disagree with our interpretation of the data; research and clinical development plans and timelines, and the regulatory process for our product candidates; future potential regulatory milestones for our product candidates, including those related to current and planned clinical studies; our ability to use and expand our therapy platform to build a pipeline of product candidates; our ability to advance product candidates into, and successfully complete, clinical trials; the timing or likelihood of regulatory filings and approvals; our estimates of the number of patients who suffer from the diseases we are targeting and the number of patients that may enroll in our clinical trials; the commercialization potential of our product candidates, if approved; our ability and the potential to successfully manufacture and supply our product candidates for clinical trials and for commercial use, if approved; future strategic arrangements and/or collaborations and the potential benefits of such arrangements; our estimates regarding expenses, future revenue, capital requirements and needs for additional financing and our ability to obtain additional capital; the sufficiency of our existing cash and cash equivalents to fund our future operating expenses and capital expenditure requirements; our ability to retain the continued service of our key personnel and to identify, hire and retain additional qualified personnel; the implementation of our strategic plans for our business and product candidates; the scope of protection we are able to establish and maintain for intellectual property rights, including our therapy platform, product candidates and research programs; our ability to contract with third-party suppliers and manufacturers and their ability to perform adequately; the pricing, coverage and reimbursement of our product candidates, if approved; developments relating to our competitors and our industry, including competing product candidates and therapies; negative impacts of the ongoing COVID-19 pandemic on our operations; our ability to comply with the continued listing standards of Nasdaq Stock Market LLC (“Nasdaq”) or the continued listing of our securities on Nasdaq; and other risks. Information regarding the foregoing and additional risks may be found in the section entitled “Risk Factors” in documents that we file from time to time with the Securities and Exchange Commission.
Forward-looking statements included herein are made as of the date hereof, and RenovoRx does not undertake any obligation to update publicly such forward-looking statements to reflect subsequent events or circumstances, except as required by law.
https://cts.businesswire.com/ct/CT?id=bwnews&sty=20231221037143r1&sid=acqr8&distro=nx&lang=en
View source version on businesswire.com: https://www.businesswire.com/news/home/20231221037143/en/
Investor Contact:
KCSA Strategic Communications
Valter Pinto or Jack Perkins
T:212-896-1254
renovorx@kcsa.com
Media Contact:
Kimberly Ha
KKH Advisors
917-291-5744
kimberly.ha@kkhadvisors.com
Source: RenovoRx, Inc.
$BLFR - Resource Rock’s past success in building successful Exploration and Production companies along with their operational expertise will greatly enhance the ability of Screaming Eagle to increase production and secure a reserve-based loan from exploration & production banks providing the capital necessary to exponentially grow the company’s daily production through workovers and newly drilled wells.
https://finance.yahoo.com/news/bluefire-equipment-corp-blfr-enters-134800795.html
$MPC $TRGP $BP $SHEL $EQNR $E $CTRA $DINO $SU $FANG $VLO $NOG $GPOR $XOM $CVX $COP $EOG $OXY $TTE $KNTK $TK
$NBIO - announces that the Company has completed payment of all outstanding variable convertible debt obligations.
https://finance.yahoo.com/news/nascent-biotech-completes-payment-variable-130000281.html
$RNXT: RenovoRx Announces Clinical Data Abstract at the 2024 Society of Interventional Radiology Annual Scientific Meeting
Research Supports RenovoRx’s Lead Oncology Product Candidate, RenovoGem™, and its Novel Therapy Platform, TAMP™, for the Treatment of Locally Advanced Pancreatic Cancer
December 19, 2023
LOS ALTOS, Calif.--(BUSINESS WIRE)-- RenovoRx, Inc. (Nasdaq: RNXT), a clinical-stage biopharmaceutical company developing novel precision oncology therapies based on a local drug-delivery platform, today announced the acceptance of a clinical data abstract for the 2024 Society of Interventional Radiology (SIR) Annual Scientific Meeting, held March 23-28 in Salt Lake City, Utah. The abstract will highlight the Company’s lead product candidate, RenovoGem, and proprietary Trans-Arterial Micro-Perfusion (TAMP) therapy platform for the treatment of Locally Advanced Pancreatic Cancer (LAPC), a difficult-to-access, solid tumor cancer.
“We are pleased to present research supporting our TAMP therapy platform at the upcoming SIR 2024 conference, the largest professional gathering of interventional radiologists in North America,” said Shaun Bagai, CEO of RenovoRx. “This research adds to the continued progress of our pivotal Phase III TIGeR-PaC study in LAPC. We remain steadfast in our commitment to deliver transformative therapies to potentially extend and improve the quality of life of cancer patients.”
Presentation Details: Title: Mesenteric Venous Thrombosis as a Predictor of Target Artery Thrombosis and Tran-Arterial Micro Perfusion Treatment Completion Among Patients with Locally Advanced Pancreatic Cancer
Authors: Michel Accad, MD, et al.
Abstract ID: 1632169
For more information about the conference, visit https://www.sirmeeting.org.
About RenovoRx, Inc.
RenovoRx is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. The Company’s proprietary Trans-Arterial Micro-Perfusion (TAMP™) therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy’s toxicities versus systemic (intravenous (IV) therapy). RenovoRx’s unique approach to targeted treatment offers the potential for increased safety, tolerance, and improved efficacy. Our Phase III lead product candidate, RenovoGem™, a novel oncology drug-device combination product, is being investigated under a US IND that is regulated by FDA 21 CFR 312 pathway. RenovoGem is currently being evaluated for the treatment of locally advanced pancreatic cancer (LAPC) by the Center for Drug Evaluation and Research (the drug division of FDA.)
RenovoRx is committed to transforming the lives of patients by delivering innovative solutions to change the current paradigm of cancer care. RenovoGem is currently under investigation for TAMP therapeutic delivery of gemcitabine and has not been approved for commercial sale.
For more information, visit www.renovorx.com. Follow RenovoRx on Facebook, LinkedIn, and Twitter.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, including but not limited to statements regarding our clinical trials and studies, including anticipated timing, statements regarding the potential of RenovoCath®, RenovoGem™ or TAMP™ or regarding our ongoing TIGeR-PaC Phase III clinical trial study in LAPC, statements regarding the potential for our product candidates to treat or provide clinically meaningful outcomes for certain medical conditions or diseases, and our preliminary financial results, cash position and related ability to continue as a going concern. Statements that are not purely historical are forward-looking statements. The forward-looking statements contained herein are based upon our current expectations and beliefs regarding future events, many of which, by their nature, are inherently uncertain, outside of our control and involve assumptions that may never materialize or may prove to be incorrect. These may include estimates, projections and statements relating to our research and development plans, clinical trials, therapy platform, business plans, objectives and expected operating results, which are based on current expectations and assumptions that are subject to known and unknown risks and uncertainties that may cause actual results to differ materially from those expressed or implied by these forward-looking statements. These statements may be identified using words such as “may,” “expects,” “plans,” “aims,” “anticipates,” “believes,” “forecasts,” “estimates,” “intends,” and “potential,” or the negative of these terms or other comparable terminology regarding RenovoRx’s expectations strategy, plans or intentions, although not all forward-looking statements contain these words. These forward-looking statements are subject to a number of risks, uncertainties and assumptions, that could cause actual events to differ materially from those projected or indicated by such statements, including, among other things: the timing of the initiation, progress and potential results of our preclinical studies, clinical trials and our research programs; the possibility that interim results may not be predictive of the outcome of our clinical trial, which may not demonstrate sufficient safety and efficacy to support regulatory approval of our product candidate, or the regulatory authority may disagree with our interpretation of the data; research and clinical development plans and timelines, and the regulatory process for our product candidates; future potential regulatory milestones for our product candidates, including those related to current and planned clinical studies; our ability to use and expand our therapy platform to build a pipeline of product candidates; our ability to advance product candidates into, and successfully complete, clinical trials; the timing or likelihood of regulatory filings and approvals; our estimates of the number of patients who suffer from the diseases we are targeting and the number of patients that may enroll in our clinical trials; the commercialization potential of our product candidates, if approved; our ability and the potential to successfully manufacture and supply our product candidates for clinical trials and for commercial use, if approved; future strategic arrangements and/or collaborations and the potential benefits of such arrangements; our estimates regarding expenses, future revenue, capital requirements and needs for additional financing and our ability to obtain additional capital; the sufficiency of our existing cash and cash equivalents to fund our future operating expenses and capital expenditure requirements; our ability to retain the continued service of our key personnel and to identify, hire and retain additional qualified personnel; the implementation of our strategic plans for our business and product candidates; the scope of protection we are able to establish and maintain for intellectual property rights, including our therapy platform, product candidates and research programs; our ability to contract with third-party suppliers and manufacturers and their ability to perform adequately; the pricing, coverage and reimbursement of our product candidates, if approved; developments relating to our competitors and our industry, including competing product candidates and therapies; negative impacts of the ongoing COVID-19 pandemic on our operations; our ability to comply with the continued listing standards of Nasdaq Stock Market LLC (“Nasdaq”) or the continued listing of our securities on Nasdaq; and other risks. Information regarding the foregoing and additional risks may be found in the section entitled “Risk Factors” in documents that we file from time to time with the Securities and Exchange Commission.
Forward-looking statements included herein are made as of the date hereof, and RenovoRx does not undertake any obligation to update publicly such forward-looking statements to reflect subsequent events or circumstances, except as required by law.
https://cts.businesswire.com/ct/CT?id=bwnews&sty=20231219375297r1&sid=acqr8&distro=nx&lang=en
View source version on businesswire.com: https://www.businesswire.com/news/home/20231219375297/en/
Investor Contact:
KCSA Strategic Communications
Valter Pinto or Jack Perkins
T:212-896-1254
renovorx@kcsa.com
Media Contact:
Kimberly Ha
KKH Advisors
917-291-5744
kimberly.ha@kkhadvisors.com
Source: RenovoRx, Inc.
$BLFR News: BlueFire Equipment Corp (BLFR) Acquires Screaming Eagle Energy, LLC., Purchasing Oil and Gas Producing Assets in Texas
Woodlands, TX., Dec. 18, 2023 (GLOBE NEWSWIRE) -- BlueFire Equipment Corp. (OTC: BLFR) (“BLFR” or the “Company”), a specialist in emerging industry acquisitions, today announces the acquisition of Screaming Eagle Energy, LLC. (“SEE”), that is currently purchasing oil and gas producing assets in Texas. The acquisition was made during the week the Company’s Interim CEO, Nickolas S. Tabraue, and Chairman of the Board, Kirk Yariger, attended an interview on OTC Stock Talk Space.
On December 14, 2023, the Company acquired 85% of SEE, a Limited Lability Corporation, formed in Texas to acquire oil and gas producing assets. There was no cash or shares of any class of the Company’s Stock in the exchange for the 85% of SEE’s membership interest.
Furthermore on the same day SEE entered into a Letter of Intent (“LOI”), to purchase producing oil and gas assets in Texas with production in excess of 1,400 BOE/day, with significant upside drilling potential, and over 25,000 acres currently held in production. SEE anticipates closing the transaction during the first quarter of 2024. The LOI is confidential and subject to the terms of the Confidentiality Agreement dated September 23, 2023.
About BlueFire Equipment Corp. (BLFR)
BLFR, after its two acquisitions in the oil and gas industry, Screaming Eagle Partners, LLC. and Screaming Eagle Energy, LLC. both operating in the state of Texas, is focused on increasing its acquisitions within the energy sector.
SAFE HARBOR ACT: Forward-looking statements are included within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding the Company’s expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations or listing on an exchange — including words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will” and other similar expressions — are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond the Company’s control and may cause actual results, performance or achievements to differ materially from anticipated results, performance or achievements. The Company is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements, whether as a result of new information, future events or otherwise. There are no assurances that the Company will complete additional acquisitions or will be successful in being approved for a NASDAQ listing. No information in this press release should be construed in any manner whatsoever as an indication of the future performance of the Company’s revenues, financial condition or stock price.
Company Contact:
Nickolas S. Tabraue
Interim CEO, Chief Compliance and Investor Relations Officer, and Director of the Board
nick@BLFR.info
Phone (786) 375-7281
$MGRX - TRYBE Labs to provide MangoRx customers with a minimally invasive FDA approved turnkey at-home blood collection services and solutions as the Company seeks to further expand its product lines requiring blood tests and results reviewed by physicians.
https://finance.yahoo.com/news/mangoceuticals-selects-trybe-labs-nationwide-133000517.html
$EVKRF News: Grid Battery Metals Announces Soil Sample Results at the Texas Springs Nevada Lithium Project Showing Average Lithium Grades of 2010 ppm
COQUITLAM, BC / ACCESSWIRE / December 14, 2023 / Grid Battery Metals Inc. (the "Company" or "Grid Battery") (TSXV:CELL)(OTCQB:EVKRF)(FRA:NMK2) announces the completed soil sample results from the first phase of its fall exploration program at its Texas Springs Property near Elko Nevada.
Background: Grid's Texas Spring Nevada Lithium Property
The Texas Springs Lithium Property adjoins the southern border of the Nevada North Lithium Project - owned by Surge Battery Metals Inc. ("Surge") (TSXV:NILI),(OTCQX:NILIF). Surge's first round of drilling identified strongly mineralized lithium bearing clays. The average lithium content within all near surface clay zones intersected in the 2022 drilling program, applying a 1000 ppm cut-off, was 3254 ppm. On September 12, 2023, Surge announced some exciting results of its most recent drilling program at this property, and recorded its highest grades to date, with up to 8070 ppm Lithium on the Northern Nevada Lithium project. These results were followed up on December 5, 2023 with a subsequent drill program yielding core drilling intercepts with assays over 7,630 ppm and multiple horizons upon deeper drilling performed.
https://www.accesswire.com/imagelibrary/445fc814-1a0b-45fc-9d1c-3ece444842cd/816805/image.png?v=3
Texas Spring Lithium Property Soil Sample Grid
https://www.accesswire.com/imagelibrary/445fc814-1a0b-45fc-9d1c-3ece444842cd/816805/image.png?v=3
https://www.accesswire.com/imagelibrary/445fc814-1a0b-45fc-9d1c-3ece444842cd/816805/image.png?v=3
Tim Fernback, Grid President & CEO comments "Now that the first phase of the exploration program is complete, we plan to gather as a group to interpret the geological data and plan our next steps at Texas Springs for the upcoming 2024 exploration season. We have some encouraging results to discuss, which is great news for our shareholders."
Mr. Seth Cude, P.G., Grid's Qualified Person comments on the results of the program "The soil sampling shows zones of strong lithium concentrations in the northwestern region of the Texas Spring Lithium property which are on trend with strong soil results from Surge Battery Metal's Nevada North Lithium project. In addition, the CSAMT data shows the Texas Spring Property exhibits several near horizontal to gently dipping subsurface horizons which may have served as paleo accumulation basins, collecting lithium bearing clays. This information, combined with the soil assay, will help us propose excellent future drilling targets."
Soil Sample Summary Results (Phase 1 Exploration Plan)
Highlights:
High grade zone in the north of > 1000ppm at lengths of 850 m x 475 m and a second high grade zone to the south of with lengths of 200 x 175 m
Clear high grade lithium zone in the northern portion of the project area is on trend with the high-grade soil samples collected in the Surge property to the north
There are 6 soil samples with Li grades over 3,000 ppm.
A total of 810 samples were collected with values ranging from 10ppm to 5610 ppm
40 samples had grades >= 1000 ppm
Using a 1000 ppm cutoff there was an average of 2010 ppm
https://www.accesswire.com/imagelibrary/445fc814-1a0b-45fc-9d1c-3ece444842cd/816805/image.png?v=3
QA/QC
Duplicate samples were taken approximately 1 in every 20 and showed excellent correlation with the originals with an r2 value of 0.9963 and a difference in average values of 2%. Standards were also inserted approximately 1 in 20 and showed an average variation of 7% with a range of 40ppm.
Sampling Protocols
GPS units with the sample locations loaded were used by the field crew to locate the sample location, and tracks GPS are taken to locate the actual location of the soil sample. Samples were taken from the b horizon and composited and sieved over a depth of 10 to 12 inches, which is standard sampling methodology for soils. Samples were transported and secured by Rangefront from the site and then were transported directly to ALS labs in Elko by Rangefront. The samples were dried and sieved to 180 microns (80 mesh) and assayed using 36 element ME-ICP41 aqua regia analysis.
Tim Fernback, Grid President & CEO comments "Completing both a detailed geophysical survey and soil sampling program is part of a methodical and systematic approach to high quality mineral exploration for claystone lithium deposits in Nevada and will allow us to select drill targets for subsequent exploration programs in the future. "
Qualified Person
Mr. Seth Cude, P.G. is a Qualified Person as defined by National Instrument 43-101 and has approved the technical information contained within this news release.
About Grid Battery Metals Inc.
Grid Battery Metals Inc. is a Canadian based exploration company whose primary listing is on the TSX Venture Exchange. The Company's maintains a focus on exploration for high value battery metals required for the electric vehicle (EV) market. http://www.gridbatterymetals.com.
About Texas Springs Property
The Company owns a 100% interest in the Texas Spring Property which consists of mineral lode claims located in Elko County, Nevada. The Property is in the Granite Range southeast of Jackpot, Nevada, about 73 km north-northeast of Wells, Nevada. The target is a lithium clay deposit in volcanic tuff and tuffaceous sediments of the Humbolt Formation.
The Texas Spring property adjoins the southern border of the Nevada North Lithium Project - owned by Surge Battery Metals Inc. ("Surge") (TSXV:NILI),(OTCQX:NILIF) and comprised of 303 mineral claims. Surge's first round of drilling identified strongly mineralized lithium bearing clays. The average lithium content within all near surface clay zones intersected in the 2022 drilling program, applying a 1000 ppm cut-off, was 3254 ppm. (Press release March 29, 2023). More recent results have shown higher grade lithium up to 8070 ppm on this property after initial drilling (Press release September 12, 2023).
About Clayton Valley Lithium Project
The Company owns a 100% interest in 113 lithium lode and placer claims covering over 640 hectares in Clayton Valley. Clayton Valley is a down-dropped closed basin formed by the Miocene age Great Basin extension and is still active due to movement along the Walker Lane structural zone. As a result, the basin has preserved multiple layers of lithium bearing volcanic ash, resulting from multiple eruptive events over the past 6 million years including eruptions from the 700,000-year-old Long Valley Caldera system and related events. These ash layers are thought to contribute to the lithium brines extracted by Albemarle and are also likely involved in the formation of the exposed lithium rich clay deposits on the east side of Clayton Valley.
Volt Canyon Lithium Property
The Company owns a 100% interest in 80 placer claims covering approximately 635 hectares of alluvial sediments and clays located 122 km northeast of Tonopah, Nevada.
About the British Columbia, Nickel Projects
The Mount Sidney Williams Group consists of three claim blocks with a total area of 10,569 hectares in the area surrounding Mount Sidney Williams, both adjoining and near the Decar project of FPX Nickel Corp., located 100 kilometres northwest of Fort St. James, B.C., in the Omineca mining division. Metallic mineralization includes nickel, cobalt, and chromium. At least some of the nickel mineralization occurs as awaruite. The Mitchell Range Group area claim consists of one claim block covering 8,659 hectares with demonstrated metallic mineralization including nickel, cobalt, and chromium. Nickel cobalt mineralization has not been well explored, but the presence of awaruite has been documented.
On Behalf of the Board of Directors
"Tim Fernback"
Tim Fernback, President & CEO
Contact Information:
Email: info@gridbatterymetals.com
Phone: 604- 428-5690
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. This news release may contain forward-looking statements which include, but are not limited to, comments that involve future events and conditions, which are subject to various risks and uncertainties. Except for statements of historical facts, comments that address resource potential, upcoming work programs, geological interpretations, receipt and security of mineral property titles, availability of funds, and others are forward-looking. Forward-looking statements are not guarantees of future performance and actual results may vary materially from those statements. General business conditions are factors that could cause actual results to vary materially from forward-looking statements.
SOURCE: Grid Battery Metals Inc.
$MGRX - Enormous growth implications
*ED medications are available to consumers over-the-counter in Mexico. That presents increased margin and sales volume potential...
*Second, Mexico is a completely untapped market as our research indicates that we will be the only company offering an ED product in a flavored rapid-dissolve tablet (RDT).”
https://finance.yahoo.com/news/mangoceuticals-launches-mangorx-mexico-subsidiary-130000423.html
Bitcoin price crash down Two Thousand so far $BTC FLASH Crash
$RXT: Artificial Intelligence (AI) and Cloud Transformation Dominate IT Investment Priorities for 2024, According to the New Rackspace Technology Survey, in Association with VMware
Businesses continue to grapple with IT recruitment and training challenges as they seek to keep up with accelerating technology advancements
SAN ANTONIO, Dec. 11, 2023 (GLOBE NEWSWIRE) -- New research by Rackspace Technology (NASDAQ: RXT), a leading end-to-end, hybrid multicloud technology solutions company, in association with VMware, finds that despite ongoing economic uncertainty, businesses are committed to prioritizing their IT investments in 2024, particularly in transformative technologies such as artificial intelligence (AI) and cloud transformation.
According to the 2024 IT Outlook Report, which surveyed 1,420 global IT professionals, 63% of organizations plan to re-calibrate their investments in 2024. Moreover, artificial intelligence dominates as the top priority, with 65% of respondents identifying pervasive artificial intelligence as the technology that will have the most significant positive impact on their organization over the next 12 months. The survey also underscores the continued adoption of the cloud. When asked about the makeup of their organization’s IT infrastructure and how it will evolve over the next 12 months, edge computing, private cloud, and public cloud increased as a percentage of workloads, while data centers, colocation facilities, and mainframes declined.
“These results highlight a decisive shift in artificial intelligence from the technical curiosity and pilot programs in 2023 to accelerating business outcomes through the industrialization of Responsible AI solutions in 2024,” said Srini Koushik, President of Technology and Sustainability at Rackspace Technology. “In the cloud arena, the increased focus on the edge and private cloud indicate that organizations are simultaneously migrating more of their critical workloads while adopting a more sophisticated workload-aware approach to their overall cloud infrastructure.”
AI Evolution
As generative AI continues to mature and grow in importance, 33% of organizations say they have either completed prototypes and are taking projects into production or already have projects underway and plan to expand them, while another 66% of respondents are either currently ideating on the use of generative AI or plan to do so. Just 1% of respondents have no plans to use generative AI. Moreover, 67% of those surveyed say they will have generative AI either integrated into some processes or fully integrated into all processes in 12 months.
While many organizations are using AI primarily for “table stakes” tasks such as sentiment analysis and code development, the use cases where respondents see the greatest expected benefit include security (54%), new product development (50%), increased productivity (45%) and enhanced speed and efficiency in existing work processes (42%).
At the same time, organizations report challenges in implementing AI programs. 42% of survey participants acknowledge demonstrating the value of AI as a hurdle, while insufficient technological infrastructure support for AI was noted by 38%, followed by a shortage of skilled IT talent, at 32%. Organizations also continue to grapple with data governance policies and strategies in response to AI. Less than half (46%) of organizations have policies or strategies in place to address privacy concerns, and only 42% say they have addressed data bias.
“While some organizations have already implemented AI-powered solutions, many are still in the early stages, grappling with the considerations and challenges associated with AI adoption,” added Koushik. “They are not just contemplating but actively addressing the issues associated with the widespread integration of AI into their business processes and operations, marking a crucial phase in their transformative journey."
Private Cloud, Edge Ascending
The survey highlights an ongoing evolution in companies’ cloud strategies as workloads migrate away from within the organization’s walls. When asked to compare their current infrastructure with their projected infrastructure composition over the next three years, private cloud rose by 4%, while public cloud saw a smaller increase, with concurrent decreases observed in workloads running on other servers, including mainframes and on-premises data centers. Edge computing is also becoming a priority, with 30% of organizations saying it will be part of their IT infrastructure makeup in 12 months, compared to 26% today. 75% of respondents say they are employing a hybrid cloud strategy today.
Survey participants identified resource shortages and security/compliance risks as their primary challenges in transitioning to the cloud, at 34%. This was followed by concerns such as cost overruns (33%), resistance to change (28%), inappropriate cloud provider selection (24%), and a lack of stakeholder buy-in (23%).
The Talent Search Dilemma
As companies prioritize AI and cloud, securing and retaining talent remains a challenge, with respondents identifying a shortage of skilled workers as their leading concern (69%). 47% of respondents also see paying more to fill critical roles, with the rapid pace of technology advancement cited as the leading cause for higher IT labor costs.
“The sustained pace and magnitude of technology advancements in AI, Cloud, Security, and other technologies demand an adaptable workforce that embraces lifelong learning,” added Koushik. “This challenge underscores the need for a different workforce strategy that prioritizes adaptability, problem-solving, and continuous learning in addition to the latest technical skills to keep pace and drive innovation forward.”
Click here to review the comprehensive 2024 IT Outlook Whitepaper and Infographic with the breakdown of survey findings.
Survey Methodology
The survey was conducted by Coleman Parkes in October and November 2023 and targeted 1,420 senior IT decision makers across multiple key sectors in the USA, LATAM, EMEA and APAC.
Coleman Parkes is a full-service B2B market research agency specializing in IT/technology studies, targeting senior decision makers in SMB to large and enterprises across multiple sectors globally.
About Rackspace Technology
Rackspace Technology is a leading end-to-end multicloud technology services company. We can design, build and operate our customers’ cloud environments across all major technology platforms, irrespective of technology stack or deployment model. We partner with our customers at every stage of their cloud journey, enabling them to modernize applications, build new products and adopt innovative technologies.
About VMware
VMware is a leading provider of multi-cloud services for all applications, enabling digital innovation with enterprise control. As a trusted foundation to accelerate innovation, VMware software gives businesses the flexibility and choice they need to build the future. Headquartered in Palo Alto, California, VMware is committed to building a better future through the company’s 2030 Agenda. For more information, please visit www.vmware.com/company.
Media Contact: Natalie Silva, publicrelations@rackspace.com
https://www.globenewswire.com/newsroom/ti?nf=ODk5Mjc0NSM1OTY2MTI4IzIwMDU3MjQ=
https://ml.globenewswire.com/media/OWFhMDE1OTMtOGRmNS00YTRhLThlNjktZGE5MDJiNDkwZjQ0LTEwMTcyOTc=/tiny/Rackspace-Technology-Inc-.png
Source: Rackspace Technology, Inc.
$EVKRF The management team behind Grid Battery Metals [TSXV: CELL; OTCQB: EVKRF] is leveraging its knowledge of the battery metals sector to create their next winner
https://resourceworld.com/grid-battery-metals-is-staged-for-success-at-is-explores-for-lithium-in-nevada/
$MGRX Benzinga Article December 07, 2023
MangoRx (MGRX) Shaping the Future of Men's Health with Global Expansion and Innovative Product Launches
https://www.benzinga.com/pressreleases/23/12/36130912/mangorx-mgrx-shaping-the-future-of-mens-health-with-global-expansion-and-innovative-product-launche
$BTZI - The Bots team will test the power of AI with end-to-end solutions through guided hands-on labs or as a development sandbox. Test, prototype, and deploy our own applications and models against the latest and greatest that NVIDIA has to offer through NVIDIA LaunchPad platform.
https://finance.yahoo.com/news/bots-inc-embarks-advanced-ai-081700886.html
$SMME News: SmartMetric Says the Imminent Release of Its Biometric Fingerprint Activated Credit Card Will Provide Massive Increased Protection for Card Users and Card Issuing Banks
NEW YORK--(BUSINESS WIRE)-- SmartMetric, Inc. (OTC: SMME) reports that the SmartMetric Gen 4 Biometric Fingerprint Card has been developed to meet the specific demand of the credit card industry and credit card users for enhanced credit card security. The card has an in-the-card a nano fingerprint scanner that is used to recognize the card holders fingerprint and in on a fingerprint match, instantly turn on the card.
“The mass market version of the SmartMetric Gen 4 biometric credit card is now under manufacture following the successful testing of the cards internal operating system on the new card platform," said Chaya Hendrick.
Reports on credit card fraud are continuing to show an exponential growth in fraud rates in the United States. According to a report released this year by Security.org 1 151 million Americans have fallen victim to credit card fraud.
65 percent of credit and credit card holders have been fraud victims at some point in their lives, up from 58 percent last year. This equates to about 151 million Americans.
An increasing number of Americans have been victimized multiple times: in 2022, 44 percent of credit card users reported having two or more fraudulent charges, compared to 35 percent in 2021
Credit Card fraud is a growing issue for both card holders and card issuing banks. The biggest under the radar cost to the consumer is the add on fraud crimes that happen following a credit card fraud instance. A growing number of credit card fraud victims become also victims of other identity theft-based crimes which can be financially devastating to card fraud victims according to SmartMetric.
“The need for a more secure credit and debit card is more needed today than ever before. That is why we have spent well over a decade in research and development to create a work anywhere at anytime biometric protected credit card," said SmartMetric’s President & CEO, Chaya Hendrick.
The SmartMetric biometric credit card is the only advanced biometric payments card product with an internal rechargeable battery that allows the card to be used in all card usage cases such as restaurants and ATM’s. Having its own power inside the card allows the SmartMetric biometric card to work prior to the card being inserted into a card reader.
The SmartMetric biometric fingerprint recognition technology built inside of the credit and debit card uses embedded biometric technology to positively recognize the card holder and then only after a positive fingerprint recognition, turn on the cards EMV contact and contactless payments chip.
According to an article published by Finder.com 2 the number of credit card accounts open in the United States is 564,500,000. This is an all-time high for the United States.
The average American owns three credit cards. 83% of Americans own at least one credit card. 14% of Americans own at least 10 credit cards.
To view the SmartMetric Biometric Card please follow this link - Video of the SmartMetric Biometric Card. To view the company website: http://www.smartmetric.com
1 2023 Credit Card Fraud Report | Security.org
2 2023 Credit card debt and spending statistics in the US | finder.com
Safe Harbor Statement: Forward-Looking Statements in this press release, which are not historical facts, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Also such forward-looking statements are within the meaning of that term in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Our actual results, performance or achievements may differ materially from those expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by the use of words such as "may," "could," "expect," "intend," "plan," "seek," "anticipate," "believe," "estimate," "predict," "potential," "continue," "likely," "will," "would" and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Such forward-looking statements are necessarily based upon estimates and assumptions that, while considered reasonable by us and our management, are inherently uncertain. Factors that may cause actual results to differ materially from current expectations include, among others, if we are unable to access the capital necessary to fund current operations or implement our plans for growth; changes in the competitive environment in our industry and the markets where we operate; our ability to access the capital markets; and other risks discussed in the Company's filings with the U.S. Securities and Exchange Commission, including our Annual Report on Form 10-K, which filings are available from the SEC. We caution you not to place undue reliance on any forward-looking statements, which are made as of the date of this press release. We undertake no obligation to update publicly any of these forward-looking statements to reflect actual results, new information or future events, changes in assumptions or changes in other factors affecting forward-looking statements, except to the extent required by applicable laws. If we update one or more forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements. Investors and security holders are urged to carefully review and consider each of SmartMetric Inc. public filings with the SEC, including but not limited to, if applicable, Annual Reports on Form 10-K, proxy statements, Current Reports on Form 8-K and Quarterly Reports on Form 10-Q.
https://cts.businesswire.com/ct/CT?id=bwnews&sty=20231206647713r1&sid=acqr8&distro=nx&lang=en
View source version on businesswire.com: https://www.businesswire.com/news/home/20231206647713/en/
SmartMetric, Inc.
Chaya Hendrick
Tel: (702) 990-3687
Mobile: (305) 607-3910 (Pacific Time)
ceo@smartmetric.com
http://www.smartmetric.com
Source: SmartMetric, Inc.
$BTZI - The Bitcoin ATM brings cryptocurrency to the masses. The device can be used to exchange cryptocurrencies, issue crypto debit cards, billing, advertising, event ticket sales, international cryptocurrency transfers, gift card sales, microloans and more.
BOTS, Inc. has partnered with MultiATM to bring this exciting product to the American consumer.
For more information about the Bitcoin ATM, please visit the link below:
https://uspto.report/patent/app/20190318326
https://bots.bz/projects-services/
$BMNR
$SUIC OTC team is harnessing the power of high technology that's reshaping the food industry and increasing food production, quality, and safety while reducing our carbon footprint.
https://finance.yahoo.com/news/suic-ihart-offers-high-tech-110000380.html
$INBS Leading Specialist Material Handling Company, Titan Cranes and Rigging Pty Ltd., Adopts Intelligent Fingerprinting Drug Screening System
https://www.globenewswire.com/news-release/2023/11/30/2788587/0/en/Leading-Specialist-Material-Handling-Company-Titan-Cranes-and-Rigging-Pty-Ltd-Adopts-Intelligent-Fingerprinting-Drug-Screening-System.html
$KNOS OTC - KRONOS ADVANCED TECHNOLOGIES, INC. announced that the Company will be offering expedited shipping and discounts on its line of Home, Schools, and Small Business Air Purifier products as well as cutting edge graphene face masks.
https://finance.yahoo.com/news/kronos-advanced-technologies-fda-cleared-101800500.html
$NBIO - Nascent Biotech Granted Japanese Patent for Crossing Blood-Brain Barrier.
The patent allowance recognizes PTB's ability to act as a monotherapy, as well as its potential to act as a conjugate, bringing other therapies across the BBB.
https://finance.yahoo.com/news/nascent-biotech-granted-japanese-patent-130000461.html
$CDSG AUGER DRILL PROGRAM TO BEGIN ON TITAN PROPERTIES
Las Vegas, NV, Nov. 29, 2023 (GLOBE NEWSWIRE) -- Titan Lithium Inc., (OTC Markets: CDSG) (the “Company” or “CDSG”) is pleased to provide an exploration update on the Titan Lithium Projects in Tanzania.
The Company has retained Dr. Joas Kabete as technical director of Kilimanjaro Lithium Ltd. to supervise an auger drilling program to better understand the geology of Titan 1. Commencement of drilling to begin this weekend at Titan 1 to a depth of 100 feet with a minimum of 5 drill holes.
At present, the lithium-in-soil anomaly at Titan 1 is the largest worldwide, covering over 40 square miles (110 square kilometers) of continuous lithium values averaging over 4,000 ppm and containing high-grade areas where lithium values returned up to 4.82% Li2O (22,400 ppm Li).
About the Company: China Dongsheng International Inc. (OTC Markets: CDSG), through its wholly owned subsidiary Titan Lithium, Inc., is a lithium explorer and developer with operations in Nevada, USA and The United Republic of Tanzania.
Contact:
Harp Sangha-Chairman
sanghaharp1964@gmail.com
+1-702-595-2247
http://www.titanlithiuminc.com
Forward-Looking Statements:
This press release may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company's ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the Company's business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company's periodic filings with the Securities and Exchange Commission.
$DFCO Special Report - 11-22-23
https://vimeo.com/884201828/c566ad2487
$CDSG ANNOUNCES TRANSFER OF PROSPECTING LICENSES IN TANZANIA
Las Vegas, NV., Nov. 17, 2023 (GLOBE NEWSWIRE) -- Titan Lithium Inc., (OTC Markets: CDSG) (the “Company” or “CDSG”) is pleased to announce it has completed the full transfer of 100% interest in the Titan 1 and Titan 2 Prospecting Licenses in Tanzania into the Company’s’ Kilimanjaro Lithium Ltd (“KLL”) subsidiary.
Mineral rights in Tanzania are held under a number of types of licenses granted under the country’s comprehensive Mining Act. Exploration projects are held by a Prospecting License (“PL”) which allows the holder to conduct a wide range of exploration work until such a time as a mining license is required for exploitation.
The vendor completed the transfer of 100% of the two Prospecting Licenses for Titan 1 and Titan 2, PL 12353/2023 and PL 12338/2023, into KLL on November 14, 2023. The Prospecting Licenses that were transferred were duly recorded pursuant to section 123(1) of the Mining Act in the central register on November 16, 2023. The licenses will be available to view on the company’s website on the “About Us” tab .
These two PLs are considered prospective to the discovery of sediment hosted lithium style mineralization within a country rich in mineral resources. Tanzania is endowed with many types of minerals including gold, iron ore, nickel, copper, cobalt, gemstones, industrial minerals as well as rare earth minerals.
Tanzania is the fourth largest gold producer in Africa and home to advanced critical mineral projects such graphite, lithium and the high-grade nickel-copper-cobalt Kabanga deposit. Earlier this year, under a Presidential plan to fast track such deposits, Tanzania signed agreements worth $667 million for graphite and rare earth projects with several Australian Mining firms. As well, in February 2023, EV maker Tesla signed an agreement under which it will purchase between 17,500 to 35,000 tons per annum of Anode Active Material (AAM) from a producer in Tanzania
“Working closely with the vendor we are very pleased to have the licenses fully transferred”, commented Chairman Harp Sangha. “Our next steps will include the commencement of work that will include a strategic drill campaign designed to produce a maiden mineral resource that we hope will elevate the projects significantly.”
About the Company: China Dongsheng International Inc. (OTC Markets: CDSG), through its wholly owned subsidiary Titan Lithium, Inc., is a lithium explorer and developer with operations in Nevada, USA, and The United Republic of Tanzania.
Contact:
Harp Sangha-Chairman
Sanghaharp1964@gmail.com
+1-702-595-2247
http://www.titanlithiuminc.com
Forward-Looking Statements:
This press release may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding the intent, belief or current expectations of the Company, its directors, or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company's ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the Company's business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company's periodic filings with the Securities and Exchange Commission.
$RGBP News: Regen BioPharma, Inc. Selects Contract Research Organization to Assist in DuraCAR Experiments
SAN DIEGO, Nov. 16, 2023 /PRNewswire/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) (OTC PINK: RGBPP) The Company has announced that after interviewing several candidates it has selected a Contract Research Organization (CRO) to perform the next set of experiments to elucidate the effectiveness of the Company's DuraCAR cells.
The Company is preparing a series of in vitro studies to test its DuraCAR cells in both immunosuppressive and in tumor-killing experiments. The experiments to explore whether these cells have an immunosuppressive effect include mixing the DuraCAR cells with activated immune cells that are designed to kill target tumor cells and to determine if these cells suppress this killing. In addition, the same experiments will be able to determine if the DuraCAR cells have a direct effect on killing tumors cells.
"We have designed a set of sophisticated experiments that test two hypotheses" says Dr. David Koos, Chairman and CEO of the company. "We have selected a CRO with excellent credentials and we expect the results to lay a clear path forward for this program."
About Regen BioPharma Inc.:
Regen BioPharma, Inc. is a publicly traded biotechnology company (PINK: RGBP) and (PINK: RGBPP). The Company is focused on the immunology and immunotherapy space. The Company is focused on rapidly advancing novel technologies through pre-clinical and Phase I/ II clinical trials. Currently, the Company is focused on mRNA and small molecule therapies for treating cancer and autoimmune disorders. Additional information on Regen BioPharma is available at http://www.regenbiopharmainc.com.
Disclaimer: This news announcement may contain forward-looking statements. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.
CONTACT INFORMATION:
Regen BioPharma Inc.
David R. Koos, Ph.D.
Chairman & Chief Executive Officer
+1-619-722-5505 Phone
+1-619-330-2328 Fax
Email: david.koos@regenbiopharmainc.com or david.koos@regenbiopharma.com
Twitter (now X): https://twitter.com/TheRegenBio
https://c212.net/c/img/favicon.png?sn=LN70703&sd=2023-11-16 View original content:https://www.prnewswire.com/news-releases/regen-biopharma-inc-selects-contract-research-organization-to-assist-in-duracar-experiments-301989889.html
SOURCE Regen BioPharma Inc.
Amazing product with multiple applications very tightly held and could move $GEVI - Report and disclosures: https://us7.campaign-archive.com/?e=[UNIQID]&u=89b57034da8c35f61c7227a1d&id=d7d8218c55
$PSLV Physical Silver is on Breaking out on new CPI inflation Data
1 oz precious metals bullion Palladium now at $1004.00 up +36.00 today
$SITS News: Southern ITS International, Inc. Subsidiary, Pure Oil & Gas, Inc., Reports on Oil Production Numbers and Announces a New 4-Well Drilling Project in Texas
Palm Desert, California, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Southern ITS International, Inc. (Pink Open Market: SITS) proudly announces a significant achievement for its subsidiary, Pure Oil & Gas, Inc., as it began sales of oil produced by one of its wells in Texas. Production in October yielded three loads of oil—510 barrels—which has been collected and sold to BML Inc.
This success sets the stage for Pure Oil & Gas, Inc.’s next venture – a four-well drilling project in Texas.
The first new well is scheduled to begin drilling in the first week of December 2023, with production anticipated to commence within four weeks of the start of drilling operations. Funding for this new project has been secured.
Jeremy Larsen, President of Pure Oil & Gas, Inc. stated, “We are thrilled to announce our successful entry into the Texas oil reserves and look forward to the promising opportunities that lie ahead with our upcoming four-well drilling project. Our strategic location in Texas provides us with a valuable resource base, and we are confident that our collaboration with ICS Energy will contribute to the efficiency and success of our drilling operations.”
Pure Oil & Gas, Inc. has partnered with ICS Energy, LLC, an experienced driller-operator with extensive expertise in the regional geological landscape. This collaboration aims to optimize operations and bolster Pure Oil & Gas's position in the energy sector.
About Pure Oil & Gas, Inc.
Pure Oil & Gas, Inc. focuses on leveraged oil and gas acquisitions as a key strategy for growth and establishing a strong position in the industry. Supported by its parent company, Southern ITS International, Inc., Pure Oil & Gas leverages financial flexibility provided by its parent to acquire leases, producing wells, oil services companies, and new oil industry technology.
About Southern ITS International, Inc.
Southern ITS International, Inc., through its subsidiary companies, currently has operations focused on a wide variety of fields, including oil and gas exploration and development, clothing, and e-commerce fulfillment. We intend to expand upon our current base of operational companies and to increase our ownership and/or control of a portfolio of highly successful businesses. As a holding company, Southern ITS International continues to be in the market to acquire a stake in various companies, both public and private, which will complement its current operations. Our mission includes establishing a robust Direct-to-Consumer (DTC) and Business-To-Business (B2B) network, harnessing the potential of e-commerce across an array of diverse sectors, including manufacturing, distribution, and product sales. We have put in place an experienced management team that is continuing to build a diverse portfolio, buying entire companies, or interests therein, involved in technology, oil and gas, manufacturing, real estate, and other sectors, which will then become operating subsidiaries of Southern ITS International.
Precautionary and Forward-Looking Statement
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may" "future," "plan" or "planned," "will" or "should," "expected," "anticipates," "draft," "eventually" or "projected." You are cautioned that such statements are subject to a multitude or risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of several factors, and other risks identified in the Company's disclosures or filings with the SEC or OTC Markets, Inc. You are further cautioned that penny stocks and stocks of smaller companies like Southern ITS International, Inc. are inherently volatile and risky, and that no investor should buy this stock unless they can afford the loss of their entire investment.
Attachments
Pure Oil & Gas Pumpjack
Contact: Southern ITS International, Inc.
Investor Relations
442-300-6522
info@sitsintl.com
Source: Southern ITS International, Inc.
TTNN Really good DD, 10.4M rev, 24M assets, completed merger
$TTNN DD Part 1 *MUST READ*
— Stock Picks NYC (@StockPicksNYC) November 2, 2023
Low volume but,
$10.5M revenues, $470K net income
Total assets $24.5M, $1M in cash
Stockholders’ equity $17.7M
$637K positive cash flow
Closest comps I could find: (Superior Plus: $SUUIF $SPB.TO), Amerigas which was bought by (UGI Corporation: $UGI)… https://t.co/WaiDGCgVP2 pic.twitter.com/lLhCHN37J2
$SMME News: SmartMetric Biometric Technology Receives Issued Patents by the United States Patent Office (USPTO)
November 13, 2023
NEW YORK--(BUSINESS WIRE)-- SmartMetric, Inc. (OTC: SMME) announced the United States Patent Office has recently issued patents that provide protection against those who decide they would like to copy the amazing advanced biometric credit card with a fingerprint sensor built into the card.
“These recently issued patents disallow others from making biometric credit cards that have a fingerprint sensor on the card according to SmartMetric.”
“A massive market for an incredible next generation credit card,” said SmartMetric’s President and CEO, Chaya Hendrick.
Over 300 million credit cards have been issued in the United States. Consumer research reveals that up to 70% of existing credit card holders are willing to pay for a biometric secured credit card.
“The SmartMetric biometric credit card has taken years to develop and its Gen4 product designed for credit card issuing banks, is now in production said SmartMetric.”
The SmartMetric biometric fingerprint activated credit card brings the power of biometric security to the regular credit and debit card. Using the cardholder's own fingerprint, only the cardholder is able to use the card. Touching the card's sensor on the card's surface awakens the card to scan the user’s fingerprint in less than a second. The fingerprint is matched with the user's pre-stored fingerprint that has been registered inside the card's internal cryptographically secured memory.
“Research has shown that up to 70% of existing credit card users are attracted to using a biometric credit card. However, for this to be achieved the card itself must be as easy and simple to use as a current credit card, and must most definitely be able to be biometric secured and safe in all card reading situations,” said Chaya Hendrick.
SmartMetric is now in mass market production of its Gen 4 advanced biometric credit card. The company is preparing to release its advanced biometric credit card to the global credit card issuing community.
The SmartMetric Gen 4 Biometric Fingerprint Card has been developed to meet the specific demand of the credit card industry and credit card users for enhanced credit card security. The card has an in-the-card nano fingerprint scanner that is used to recognize the card holder's fingerprint and in turn activate the card.
The SmartMetric biometric credit card is the only advanced biometric payments card product with an internal rechargeable battery that allows the card to be used in all card usage cases such as restaurants and ATM’s. Having its own power inside the card allows the SmartMetric biometric card to work prior to the card being inserted into a card reader.
The SmartMetric biometric fingerprint recognition technology built inside of the credit and debit card uses embedded biometric technology to positively recognize the card holder and then only after a positive fingerprint recognition, turn on the card's EMV contact and contactless payments chip.
According to an article published by Finder.com 2 the number of credit card accounts open in the United States is 564,500,000. This is an all-time high for the United States.
The average American owns three credit cards. 83% of Americans own at least one credit card. 14% of Americans own at least 10 credit cards.
SmartMetric plans to sell its advanced biometric credit card to card issuing banks for $50.00 a card. In turn, banks will decide whether or not to provide the card for free to its card users or offer it as a premium card to its top tier card users for a fee.
To view the SmartMetric Biometric Card please follow this link - Video of the SmartMetric Biometric Card. To view the company website: http://www.smartmetric.com
1 2023 Credit Card Fraud Report | Security.org
2 2023 Credit card debt and spending statistics in the US | finder.com
Safe Harbor Statement: Forward-Looking Statements in this press release, which are not historical facts, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Also such forward-looking statements are within the meaning of that term in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Our actual results, performance or achievements may differ materially from those expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by the use of words such as "may," "could," "expect," "intend," "plan," "seek," "anticipate," "believe," "estimate," "predict," "potential," "continue," "likely," "will," "would" and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Such forward-looking statements are necessarily based upon estimates and assumptions that, while considered reasonable by us and our management, are inherently uncertain. Factors that may cause actual results to differ materially from current expectations include, among others, if we are unable to access the capital necessary to fund current operations or implement our plans for growth; changes in the competitive environment in our industry and the markets where we operate; our ability to access the capital markets; and other risks discussed in the Company's filings with the U.S. Securities and Exchange Commission, including our Annual Report on Form 10-K, which filings are available from the SEC. We caution you not to place undue reliance on any forward-looking statements, which are made as of the date of this press release. We undertake no obligation to update publicly any of these forward-looking statements to reflect actual results, new information or future events, changes in assumptions or changes in other factors affecting forward-looking statements, except to the extent required by applicable laws. If we update one or more forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements. Investors and security holders are urged to carefully review and consider each of SmartMetric Inc. public filings with the SEC, including but not limited to, if applicable, Annual Reports on Form 10-K, proxy statements, Current Reports on Form 8-K and Quarterly Reports on Form 10-Q.
https://cts.businesswire.com/ct/CT?id=bwnews&sty=20231113074037r1&sid=acqr8&distro=nx&lang=en
View source version on businesswire.com: https://www.businesswire.com/news/home/20231113074037/en/
Chaya Hendrick
Tel: (702) 990-3687
Mobile: (305) 607-3910 (Pacific Time)
ceo@smartmetric.com
http://www.smartmetric.com
Source: SmartMetric, Inc.
$SMME News: SmartMetric Says Restricted Useage and Difficult Fingerprint Enrollment by Copycat Biometric Cards Will Doom Them to Failure – the SmartMetric Biometric Card Is Designed for Ease of Use Anytime and Anywhere
November 10, 2023
NEW YORK--(BUSINESS WIRE)-- SmartMetric, Inc. (OTC: SMME) is of the view that poorly thought out and less advanced copycat biometric credit cards will result in these inferior cards failing in the market.
“For a biometric credit card to succeed in market adoption and use the card must be as simple to input your fingerprint biometrics into the card as that experienced using a mobile phone. It also needs to be able to be used as a biometric secured card at all touch points (readers) as a standard credit or debit card. Anything short of this will lead to consumers not adopting biometric card technology,” said SmartMetric’s President and CEO, Chaya Hendrick.
A couple of copycat biometric credit cards have been trialed in Europe that require the user to go to a bank branch to register their fingerprint into the card. These same cards do not provide biometric protection at ATMs and most gas stations. They disengage the biometric protection function for these readers, voiding the biometric protection that the card users were promised when using these cards.
The biggest single reason for the clumsy, inefficient and, to coin a phrase, “friction laden” card is because they do not have an internal power source inside the card, making the biometric function unworkable when a card reader is “swallowed” by the card reader, according to Chaya Hendrick.
SmartMetric realized early on in its quest for developing a biometric credit card that the card needed to be as frictionless and as easy to use as a current credit card, otherwise its adoption would meet card user resistance. To this end SmartMetric has spent a great deal of time and resources in creating a biometric credit card that has its own rechargeable internal power built inside the card.
“Research has shown that up to 70% of existing credit card users are attracted to using a biometric credit card. However, for this to be achieved the card itself must be as easy and simple to use as a current credit card and must most definitely be able to be biometric secured and safe in all card-reading situations,” said Chaya Hendrick.
SmartMetric is now in mass market production of its Gen 4 advanced biometric credit card. The company is preparing to release its advanced biometric credit card to the global credit card issuing community.
Being the original creator of biometric credit cards, SmartMetric is poised to lead the world in the manufacturing and release of biometric credit cards for sale to card-issuing Banks.
The SmartMetric Gen 4 Biometric Fingerprint Card has been developed to meet the specific demand of the credit card industry and credit card users for enhanced credit card security. The card has an in-the-card nano fingerprint scanner that is used to recognize the card holder's fingerprint and in turn activate the card.
The SmartMetric biometric credit card is the only advanced biometric payments card product with an internal rechargeable battery that allows the card to be used in all card usage cases, such as restaurants and ATMs. Having its own power inside the card allows the SmartMetric biometric card to work prior to the card being inserted into a card reader.
The SmartMetric biometric fingerprint recognition technology built inside of the credit and debit card uses embedded biometric technology to positively recognize the card holder and then, only after a positive fingerprint recognition, turn on the card's EMV contact and contactless payments chip.
According to an article published by Finder.com 2 the number of credit card accounts open in the United States is 564,500,000. This is an all-time high for the United States.
The average American owns three credit cards. 83% of Americans own at least one credit card. 14% of Americans own at least 10 credit cards.
SmartMetric plans to sell its advanced biometric credit card to card issuing Banks for $50.00 a card. In turn Banks will decide whether or not to provide the card for free to its card users or offer it as a premium card to its top tier card users for a fee.
To view the SmartMetric Biometric Card please follow this link - Video of the SmartMetric Biometric Card. To view the company website: http://www.smartmetric.com
1 2023 Credit Card Fraud Report | Security.org
2 2023 Credit card debt and spending statistics in the US | finder.com
Safe Harbor Statement: Forward-Looking Statements in this press release, which are not historical facts, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Also such forward-looking statements are within the meaning of that term in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Our actual results, performance or achievements may differ materially from those expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by the use of words such as "may," "could," "expect," "intend," "plan," "seek," "anticipate," "believe," "estimate," "predict," "potential," "continue," "likely," "will," "would" and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Such forward-looking statements are necessarily based upon estimates and assumptions that, while considered reasonable by us and our management, are inherently uncertain. Factors that may cause actual results to differ materially from current expectations include, among others, if we are unable to access the capital necessary to fund current operations or implement our plans for growth; changes in the competitive environment in our industry and the markets where we operate; our ability to access the capital markets; and other risks discussed in the Company's filings with the U.S. Securities and Exchange Commission, including our Annual Report on Form 10-K, which filings are available from the SEC. We caution you not to place undue reliance on any forward-looking statements, which are made as of the date of this press release. We undertake no obligation to update publicly any of these forward-looking statements to reflect actual results, new information or future events, changes in assumptions or changes in other factors affecting forward-looking statements, except to the extent required by applicable laws. If we update one or more forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements. Investors and security holders are urged to carefully review and consider each of SmartMetric Inc. public filings with the SEC, including but not limited to, if applicable, Annual Reports on Form 10-K, proxy statements, Current Reports on Form 8-K and Quarterly Reports on Form 10-Q.
https://cts.businesswire.com/ct/CT?id=bwnews&sty=20231110004682r1&sid=acqr8&distro=nx&lang=en
View source version on businesswire.com: https://www.businesswire.com/news/home/20231110004682/en/
SmartMetric, Inc.
Chaya Hendrick
Tel: (702) 990-3687
Mobile: (305) 607-3910 (Pacific Time)
ceo@smartmetric.com
http://www.smartmetric.com
Source: SmartMetric, Inc.
$BLFR News: BlueFire Equipment Corp (BLFR) Reduces Authorize Common Stock, Increases Series A Preferred Stock for Future Acquisitions, and Shares Updates on the Binding Letter Agreement with Resource Rock Exploration, LLC
Woodlands, TX. , Nov. 08, 2023 (GLOBE NEWSWIRE) -- BlueFire Equipment Corp. (OTC: BLFR) (“BLFR” or the “Company”), a specialist in emerging industry acquisitions, today announces the reduction of the Company’s Authorize Common Stock, increase of the Company’s Series A Preferred Stock, and updates on the Binding Letter Agreement with Resource Rock Exploration, LLC. (“Resource Rock”).
Authorize Common Stock Reduction:
On November 7, 2023, the Company reduced its Authorized Common Stock from 2 billion shares to 250 million shares. The Company anticipates OTC Markets to reflect the change by November 15, 2023, based on recent communication with the Transfer Agent. Management does not see the need on having more than 250 million shares authorized based on its current operations and plans.
Series A Preferred Stock Increase:
On November 7, 2023, the Company increased its Series A Preferred Stock from 50 million shares to 99 million shares. Management increased the Company’s Series A Preferred Stock for future potential acquisitions.
Resource Rock Exploration, LLC. Binding Agreement Update:
The expected execution date of the Joint Operating Agreement (“JOA”) has been extended from on or before November 3, 2023 as the agreement is still under legal review. Screaming Eagle’s cash compensation for its 12.5% interest will be received upon executing the JOA.
About BlueFire Equipment Corp. (BLFR)
BLFR, after its first acquisitions in the oil and gas industry Screaming Eagle Partners, LLC. operating in the state of Texas, has gained traction and momentum to focus on increasing its acquisitions within the energy sector.
SAFE HARBOR ACT: Forward-looking statements are included within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding the Company’s expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations or listing on an exchange — including words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will” and other similar expressions — are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond the Company’s control and may cause actual results, performance or achievements to differ materially from anticipated results, performance or achievements. The Company is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements, whether as a result of new information, future events or otherwise. There are no assurances that the Company will complete additional acquisitions or will be successful in being approved for a NASDAQ listing. No information in this press release should be construed in any manner whatsoever as an indication of the future performance of the Company’s revenues, financial condition or stock price.
Company Contact:
Nickolas S. Tabraue
Interim CEO, Chief Compliance and Investor Relations Officer, and Director of the Board
info@BLFR.info
Phone (786) 375-7281
https://www.globenewswire.com/newsroom/ti?nf=ODk3NTQwNiM1OTE3ODMwIzUwMDEwOTA5MQ==
https://ml.globenewswire.com/media/ZGJlMzIzNGUtODA5ZC00OTdhLThlOTItODhmNGNmZTc3M2UxLTUwMDEwOTA5MQ==/tiny/BlueFire-Equipment-Corp-.png
Source: BlueFire Equipment, Corp.
Followers
|
526
|
Posters
|
|
Posts (Today)
|
1
|
Posts (Total)
|
45976
|
Created
|
02/21/10
|
Type
|
Free
|
Moderator MaxPowerLove$Ihub | |||
Assistants mick Ask$lapper k124Inv RoadRunner3 |
Welcome!
Sad =( Not Funny! But it's True!
Remember, The OTC Market is like Vegas! Treat trading & investing in every penny stocks like Casino gambling!
Check out some of our picks & results in the past:
Recent Plays:
Le2dynasty: Alerted for CBYI in late March @ the point when the stock was at no bid. A few weeks later the PPS reached .0004s (400% gain)
Le2dynasty: Alerted for GRPS (together with KGRI, CBYI) @ .0001s on May 17th...On May 23rd the PPS touched .0012s (1,200% gain)
Le2dynasty: Alerted for CBYI @ .0001s on May 23rd -- early morning & within a few hours, the PPS reached .0003s with mega trading volume-- (71 mil. total trading vol. with 99% buyin' vol.) (300% gain)
Le2dynasty: Alerted for CBYI @ .0002s on May 24rd -- early morning & immediately, the PPS reached .0004s with mega trading volume -- (more than 100 mil. total trading vol. CBYI was the top in top trading vol. on this day) (100% gain)
Le2dynasty: Alerted for EMLL @ .0002s on July 2nd -- early morning & the PPS reached .0004s with mega trading volume -- (more than 260 mil. total trading vol. EMLL became the top in top trading vol. & top in breakout board on this day) (50% gain)
Le2dynasty: Alerted for HIRU @ .0001s on July 3rd & on July 9, HIRU reached .0006s with mega trading volume (600% gain)
Le2dynasty: Alerted for IMDS @.0005s on July 9 @ the pt. when the total trading vol. is below 80 mil. Within 50 minutes later, the PPS reached .0009s, with more than 245 mil. total trading vol. (80% gain) in less than 1 hr. On July 10th another alert was sent out to remind traders/investors & on July 12th, the PPS reached .0026s..that is more than (500% gain) since July 9 alert.
Le2dynasty: Alerted for NVAE in early moring @ the pt. when the stock was @ no bid. PPS then reached .0003s (200% again) with a mega trading vol. (end the trading day with more than 230 mil total trading vol.). Unfortunately, the the stock dropped back to .0001 at closing.
BurntOrang3: : 400-500% gains off of DRGI after the alert
BurntOrang3: : Over 100% gains after my AUCI alert
**** Attention: Mods, Please don't edit the ibox w/o asking me first, b/c there are some kind of coding problems here ...and the IH Greeks ...Especially IH Greek (Dave) had spent a lot of time fixing this. Thank you Dave and thank all the mods here as well ****
Our Associates:
TheKingPennyStock
Daily 000X Plays
Monster Day Traders
Pinky With Potential!
BOTTOM PLAYS! CHART TECH! RESEARCH! STRATEGIES!
"A Dawgg"
Billionaire Boys Club Member Forum (BBCMF)
THE WALL STREET CLUB
$THE WAVE
THE BLUE EXCHANGE
ALERTS, CHARTS, & HOT STOCKS
Momentum Players
Momentum Runners
MOMO'S BREAKOUT BOARD
STOCKGOODIES PLAYS OF THE WEEK
Welcome To The Zoo
~~~TEFFY''S~~~HOT~~~PROFILED~~~PICKS~~~
Another Winning Trade
CASH COW
EZ Traders Forum
NO BRAINERS
StocksDiva Bio Bin
Pinto Beans and Money Making Stock Picks
PINKSHEET Breakout Board!!!
Picks For Every Play
Penny Stock Millionaire
The Van Scan
UNDERVALUED PENNY STOCKS
The Penny Stock Grow Room
Wowza board
Disclaimer: We are not investment advisors. We recommend investors to do their own due diligence. Never invest in any stock unless you can afford to lose your entire investment. Opinions expressed on this board are only opinions.
PER IHUB MGMT |
02-07-2021
DISCLAIMER: ONLY FOR MICK
https://investorshub.advfn.com/boards/profilea.aspx?user=1012
*The Board Monitor and herewithin , are not licensed brokers and assume NO responsibility for actions,
investments,decisions, or messages posted on this forum.
CONTENT ON THIS FORUM SHOULD NOT BE CONSIDERED ADVISORY NOR SOLICITATION
AUTHORS MAY HAVE BUYS OR SELLS WITH THE COMPANIES MENTIONED IN TRADING POSTERS SHOULD DUE DILIGENT BUYING OR SELLING.
ALL POSTING SHOULD BE CONSIDERED FOR INFORMATION ONLY. WE DO NOT RECOMMEND ANYONE BUY OR SELL ANY SECURITIES POSTED HEREWITHIN.
ANY trade entered into risks the possibility of losing the funds invested.
• There are no guarantees when buying or selling any security.Any
Posts Today
|
1
|
Posts (Total)
|
45976
|
Posters
|
|
Moderator
|
|
Assistants
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |